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ABSTRACT 
Circulating blood volume is reduced during spaceflight, making astronauts 
hemodynamically compromised.  After landing, astronauts separate into two groups.  One 
group compensates for the hypovolemia with a hyper-sympathetic response during 
upright tilt testing and can complete a tilt test with few symptoms.  The other group is 
unable to mount a hyper-sympathetic response and experiences orthostatic hypotension 
and presyncope during upright tilt tests.  We tested the hypothesis that hypovolemia 
alone, in the absence of spaceflight, also would cause subjects to separate into 
presyncopal and non-presyncopal groups according to their sympathetic responses during 
tilt.  We studied 20 subjects, including 10 veteran astronauts, on three occasions.  On 
Days 1 (normovolemia) and 3 (hypovolemia), plasma volume, tilt tolerance and supine 
and standing plasma norepinephrine levels were measured.  Forty hours prior to Day 3, 
subjects were given intravenous furosemide, followed by 36 hours of a 10MEq Na diet.  
Statistical comparisons were made between normovolemia and hypovolemia responses.  
This protocol reproduced landing day tilt test outcomes with 100% fidelity in the 
astronauts.  Similarly to patterns reported after flight, non-presyncopal subjects had 
greater norepinephrine responses to tilt during hypovolemia compared to normovolemia 
(580±79 vs. 298±37 pg/ml, P<0.05), but presyncopal subjects had no increase (180±44  
vs. 145±32 pg/ml, P=NS).  This model can be used to predict astronauts who will become 
presyncopal on landing day, so that prospective, individualized countermeasures can be 
developed.  Within patient populations, it can be used to study the interaction of volemic 
state and the sympathetic nervous system. 
INTRODUCTION 
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   The study of human physiological changes during spaceflight often leads to 
findings that can be relevant to clinical populations.  Spaceflight challenges the human 
body with physiological stresses that must be overcome for survival.  Sometimes these 
stresses unmask symptoms that would not manifest under normal conditions.  A major 
physiological change that all astronauts experience and must overcome is a reduction in 
circulating blood volume of about 9% (2, 3, 10).  This results from a diuresis initiated by 
the cephalad fluid shifts upon entry into microgravity.  While not of much hemodynamic 
importance during microgravity, this fluid loss is a prime example of a physiological 
change for which other systems must compensate if astronauts are to function normally 
after landing.  During postflight testing of orthostatic tolerance, only those who can 
mount an extra-ordinary sympathetic response are able to maintain upright blood 
pressures during stand or tilt tests.  A substantial percentage of astronauts cannot mount 
such a response and experience severe orthostatic hypotension and presyncope or 
syncope.  We have documented this repeatedly over the last 15 years (2, 3, 10, 13).  The 
ability to predict, before flight, who those astronauts will be on landing day would be a 
major breakthrough for the development of appropriate countermeasures.  To date, the 
only predictor of postflight orthostatic hypotension and presyncope has been the outcome 
from a prior flight (7).  Preflight identification has been made difficult by the fact that, 
prior to flight, large sympathetic responses are not needed to maintain upright posture, 
and incidents of presyncope are very rare in these normal healthy astronauts.  We 
theorized that, since loss of blood volume is a large driver of postflight orthostatic 
hypotension, it may be possible to reproduce the landing day presyncope by reproducing 
the landing day hypovolemia.  In a ground-based study, we used a regimen of an 
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intravenous dose of furosemide plus a low salt diet to induce hypovolemia.  We tested the 
hypothesis that the incidence of presyncope during upright tilt testing would be the same 
during hypovolemia as on landing day, and that the underlying cause would be 
inadequate compensatory sympathetic responses.  If true, we would have a model that 
could provide a means by which individuals that would become presyncopal after 
spaceflight could be identified before launch, so that countermeasures could be 
prescribed prospectively for them.   
METHODS  
This study was approved by the Johnson Space Center Committee for the 
Protection of Human Subjects.  All subjects signed informed consent documents.  
Subjects were 13 men and 7 women, aged 40.9 + 2 years.  Nine of these were astronauts 
(six men and three women), for whom we were able to compare their previous preflight 
and postflight tilt test outcomes with their current normovolemia and hypovolemia tilt 
test outcomes.  Subjects came to the laboratory on three occasions.  On day 1 
(normovolemia day), subjects had consumed a minimum of 2 grams of NaCl every day 
for a week.  On day 2, subjects had voluntarily reduced their salt intake for the prior three 
days.  Initial hypovolemia was achieved by the slow infusion of 0.5 mg/kg of furosemide 
at a rate of 4 mg/min.  This was followed by 36 hours of a very low sodium diet 
(10mEq/day).  Day 3 (hypovolemia day) began 40 hours after the furosemide infusion.  
Days 2 and 3 were separated by at least two weeks.  For all female subjects, Days 1 and 3 
were always performed during menses, and in random order.  Tilt tests were performed 
on days 1 and 3.  On each study day, subjects had abstained from taking any medications 
for the previous 24 hours, had not eaten a heavy meal within 4 hours, had consumed a 
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light snack within 2 hours, and had not exercised maximally within 24 hours.  Subjects 
were placed supine on a tilt table and instrumented for ECG, brachial artery pressure and 
beat-to-beat finger arterial pressure. An intravenous catheter was placed in an antecubital 
vein for blood draws.  The subject then rested supine on the table for 20 minutes, at 
which time plasma volume was measured using the carbon monoxide rebreathing 
technique (1, 6).  A blood sample was drawn for plasma norepinephrine and epinephrine 
levels.  Measurements of heart rate and arterial pressure were obtained for 5 minutes, 
after which the tilt table was inclined to 80o upright.  Measurements continued for 15 
minutes and a final blood sample was drawn.  If presyncopal symptoms caused early 
termination of the tilt test, the table was returned to the supine position and blood was 
drawn immediately.  Catecholamines were later measured by radioenzymatic assay (4).   
Statistics 
Statistical comparisons were made only for the normovolemia and hypovolemia data 
collected in the current study.  All results are presented as means + SE.  All data from the 
current study were tested for normalcy and equal variance using the Kolmogorov-
Smirnov test and the Levene Median test.  Subjects were grouped into presyncopal or 
non-presyncopal, based on their ability to complete the tilt test on the hypovolemia test 
day (Day 3).  Differences were analyzed by using a two-way repeated measures analysis 
of variance.  The effects of interest were group (presyncopal or non-presyncopal) and day 
(normovolemia or hypovolemia).  The Tukey test for multiple comparisons was 
performed to document differences when there were significant main effects.  For all 
tests, significance was set at P < 0.05.   
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Statistical comparisons were not made between prior flight data and current 
hypovolemia data.  Of the nine astronauts who participated in this ground-based study, 
preflight/postflight catecholamine and plasma volume data were available for only six.  
Of those six, four were presyncopal on landing day and two were not.  These numbers 
were not large enough to allow statistical comparisons between their flight and their 
hypovolemia data.  However, flight data from previous publications have been re-plotted 
and are presented in figures 1, 4 and 5 for comparison with the current data.   
RESULTS 
Plasma Volumes    
 Figure 1 presents plasma volume losses in the non-presyncopal and presyncopal 
subjects in the current study (right).  Previously published spaceflight-induced plasma 
volume loss data have been re-plotted and are presented for comparison on the left.  
There were no differences between presyncopal and non-presyncopal subjects in either 
situation. 
Supine Arterial Pressure and Heart Rate 
There were no differences in baseline arterial pressure between normovolemia and 
hypovolemia or between presyncopal and non-presyncopal groups, but heart rates were 
higher with hypovolemia in both groups.  In the non-presyncopal group baseline systolic 
and diastolic pressures were 118 + 6 mmHg and 69 + 4 mmHg during normovolemia and 
120 + 4 mmHg and 70 + 3  mmHg during hypovolemia (P = NS).  In the presyncopal 
group pressures were 113 + 3 mmHg and 64 + 3 mmHg during normovolemia and 111 + 
4 mmHg and 66 + 2 mmHg during hypovolemia (P = NS).  Heart rates were higher 
during hypovolemia than normovolemia in both groups; 63 + 3 bpm vs. 70 + 5 bpm (P = 
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0.003) in the non-presyncopal group and 52 + 2 bpm vs. 59 + 2 bpm (P = 0.003) in the 
presyncopal group.   Resting heart rate was significantly lower in the presyncopal group 
than in the non-presyncopal group during both normovolemia (P = 0.04, between groups) 
and hypovolemia (P = 0.03, between groups). 
Orthostatic Tolerance 
Of the nine astronaut subjects who participated in this study, their landing day tilt 
test outcomes were reproduced by hypovolemia with 100% fidelity.  Six of them became 
presyncopal during tilt tests both on landing day and during hypovolemia; three did not.  
Of all subjects in this study, 55% were presyncopal during hypovolemia.  Figure 2 
presents original tilt tests during normovolemia and hypovolemia for one non-
presyncopal subject (top two panels) and one presyncopal subject (bottom two panels).  
The susceptible subject became presyncopal at five minutes of tilt on the hypovolemia 
day.   
Norepinephrine Responses 
Figure 3 presents supine and standing plasma norepinephrine levels for the same two 
subjects during normovolemia and hypovolemia.  The two subjects had similar increases 
in norepinephrine levels during upright tilt when they were normovolemic.  During 
hypovolemia, they had similar increases in supine plasma norepinephrine levels.  
However, when hypovolemic, the presyncopal subject had no additional increase in 
response to tilt, while the non-presyncopal subject had a greater than two-fold increase.  
Complete norepinephrine and epinephrine data were obtained in 17 of the 25 subjects in 
the current study.  Figure 4 presents normovolemia vs. hypovolemia norepinephrine 
responses to upright tilt in non-presyncopal (top, right) and presyncopal (bottom, right) 
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subjects in the current study.  Previously published preflight vs. postflight norepinephrine 
responses to tilt in non-presyncopal and presyncopal astronauts have been re-plotted and 
are presented for comparison on the left.  It is significant that, both on landing day and 
during hypovolemia alone, presyncopal subjects do not increase their release of 
norepinephrine, while, non-presyncopal subjects have at least a two-fold increase.   
Epinephrine Responses 
 Figure 5 presents norepinephrine responses to upright tilt during normovolemia 
and hypovolemia in non-presyncopal (top, right) and presyncopal (bottom, right) subjects 
in the current study.  Previously published preflight vs. postflight epinephrine responses 
to upright tilt in non-presyncopal and presyncopal astronauts have been re-plotted and are 
presented for comparison on the left.  Unlike the norepinephrine response, the 
epinephrine response to tilt is significantly greater during presyncopal episodes after 
spaceflight, but significantly smaller during presyncopal episodes during hypovolemia.   
DISCUSSION 
This study describes a very important finding; that if astronauts and normal subjects are 
subjected to a similar level of hypovolemia as that experienced after spaceflight, they will 
self-separate into those who do and those who do not become presyncopal during a 
simple upright tilt test.  In the astronauts whom we tested in both conditions, the 
hypovolemia reproduced the occurrence of presyncope with 100% fidelity.  Moreover, 
the mechanism of presyncope in both conditions is the same; the failure to mount the 
super-sympathetic response needed to overcome the hemodynamic compromise caused 
by the hypovolemia. 
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This model can provide new opportunities for the study of mechanisms of blood pressure 
control.  By driving subjects into this compromised hemodynamic state, the limits of 
sympathetic responsiveness can be measured.  Within the astronaut population, it offers 
the means by which astronauts who will be susceptible to postflight orthostatic 
hypotension can be identified prior to their first flight, so that countermeasure treatments 
can be individualized and prescribed prospectively.  Within patient populations the model 
could be useful in the study of the interaction of volemic state and the sympathetic 
nervous system in both hypotension and hypertension 
Spaceflight Relevance 
Our group has several publications about post-spaceflight orthostatic hypotension 
that include data from over 100 astronaut subjects.  In each study we found subtle 
differences, before flight, in the responses of presyncopal and non-presyncopal astronauts 
to upright tilt (2, 3, 10, 13).  However, the differences were not great enough to allow us 
to predict which crew members would experience orthostatic hypotension and 
presyncope after landing.  The current study is a breakthrough in this effort.  We have 
shown that post-spaceflight orthostatic hypotension and presyncope can be reproduced 
with a hypovolemia regimen on the Earth.  Furthermore, we have shown that the 
underlying cause of the orthostatic hypotension in both situations is hypo-adrenergic 
responsiveness.  It will now be possible to test potential countermeasures on susceptible 
individuals with some confidence that, if the countermeasure is effective during 
hypovolemia, it will be effective on landing day.  This model also offers the opportunity 
to perform preliminary screening of potential countermeasures before expensive head-
down tilt bed rest studies (the human ground-based analog of spaceflight) are undertaken. 
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This model already has allowed us to compare the effects of hypovolemia alone 
with the effects of spaceflight on left ventricular mass, an area of some controversy.  It 
had been suggested by some that decreases in left ventricular mass after spaceflight might 
indicate cardiac atrophy associated with cardiovascular deconditioning (5).  However, 
this same hypovolemia regimen reproduces the postflight decrease in left ventricular 
mass (12).  This suggests that the postflight reductions in mass may be secondary to 
simple physiologic fluid exchanges.  Other cardiovascular changes after spaceflight, such 
as decreased aerobic capacity, also have a large hypovolemic component.  The same 
hypovolemia regimen could be used for evaluation of that phenomenon. 
Many attempts have been made to restore plasma volume losses in astronauts 
prior to their return to Earth.  To date they have not been successful.  All of the astronaut 
subjects who have been evaluated in our flight studies had consumed the required fluid 
load of salt tablets and water (or its equivalent) prior to landing.  Still they average a 9% 
loss of plasma volume after both short (3, 13), and long-duration flights (8).  However, 
the key to postflight orthostatic tolerance has been shown not to be the degree of plasma 
volume loss, but rather the degree that the sympathetic nervous system can compensate 
for that loss (3, 8, 13).  Therefore, our more recent countermeasure development efforts 
have focused on α-adrenergic agonists to supplement sympathetic responses.  The α-
agonist midodrine has shown initial success in preventing postflight orthostatic 
hypotension (11), probably will not be appropriate for all crew members.  The new 
hypovolemia model would be very effective in identification of target crew members.  It 
may also be used to compare relative efficacy of other new countermeasures, as they 
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become available.  It could eventually be used as a selection criterion for flight 
assignments.   
It is important to note that this model may “under-predict” susceptibility after 
longer duration missions, which last months rather than days.  We have shown that even 
crew members who were classified as non-presyncopal after short Shuttle flights become 
presyncopal after long flights (9).  It is thought that a central remodeling occurs as flight 
progresses due to lack of afferent baroreceptor input, such that efferent sympathetic 
responses may be blunted (10).  The usefulness of this hypovolemia model for longer 
flights will be mostly in preflight comparisons of the efficacy of various countermeasures 
or combinations of countermeasures. 
Clinical Relevance  
The implications of these findings extend beyond the arena of space medicine and 
physiology.   They also have relevance for the study of clinical populations who have 
poor control of blood pressure.  Our results show that within the normal population, there 
are at least two different patterns that reflect differences in sympathetic control of arterial 
pressure.  It is possible that these patterns are exaggerated in pathological conditions.  It 
is clear that one pattern of response results in hypotension.  Many patients with 
autonomic neuropathies have symptoms similar to those of returning astronauts, and their 
volume status is critical to their overall status. Thus this model could be used to study 
those patients.   
Could the other pattern of sympathetic response during hypovolemia relate to 
hypertension?  Yun et al. have suggested that, in salt-resistant hypertension, fluid losses 
associated with prescribed diuretics may actually trigger a reflex-mediated increase in 
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sympathetic drive which acts to increase pressure.  They suggest that these patients might 
be better treated with hydration, which has beneficial effects on many conditions that are 
associated with heightened sympathetic activity (such as acute coronary syndrome, 
asthma, cancer and stroke) (14).  Our results directly relate to this possibility, which also 
warrants further study.   
Summary 
 We report a new model with which sympathetic control of blood pressure can be 
studied.  We identified two patterns of sympathetic responsiveness within the normal 
population. One group of subjects was unable to increase sympathetic responsiveness to 
upright tilt when hypovolemia.  These subjects experienced orthostatic hypotension and 
presyncope.  Subjects who were able to mount a larger sympathetic response when 
dehydrated did not experience such symptoms.  This model can facilitate study of 
differences in autonomic control of blood pressure after spaceflight, between genders and 
in several disease states.  
Limitations 
 This study suffered from the fact that not all of the plasma volumes and 
norepinephrine data were available for preflight and postflight studies.  Consequently 
statistical analyses were appropriate only between the normovolemia and hypovolemia 
data.  Statistical comparisons were not performed between flight and hypovolemia data.  
However, since astronauts are, in fact, normal healthy subjects, and the patterns of 
adrenergic insufficiency are so similar between landing day and hypovolemia alone, we 
do not believe this distorts the results. 
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Figure Legends 
 Figure 1. Normovolemia to hypovolemia plasma volume losses in non-
presyncopal and presyncopal subjects (right).  Previously published preflight to postflight 
plasma volume losses in astronauts have been re-plotted and are presented for 
comparison on the left (10).  There are no differences between presyncopal and non-
presyncopal subjects in either group.   
 Figure 2.   Original tracings of arterial pressure and heart rate from tilt tests 
during normovolemia and hypovolemia in one non-presyncopal subject (top) and one 
presyncopal subject (bottom).  Note that the presyncopal subject remained upright for the 
entire test on the normovolemia day, but only withstood five minutes upright on the 
hypovolemia day.  The heavy arrows begin at the time of tilt.       
Figure 3. Supine and standing plasma norepinephrine levels from the two subjects 
shown in Figure 2, during normovolemia and hypovolemia.  The presyncopal subject had 
the same change in norepinephrine on both days.  The non-presyncopal subject had twice 
the response during hypovolemia compared to normovolemia. 
Figure 4.  Norepinephrine responses to tilt during normovolemia and 
hypovolemia in non-presyncopal and presyncopal subjects (right).  Previously published 
preflight and postflight norepinephrine responses to tilt have been re-plotted and are 
presented for comparison on the left (11).  Note the similarity between the change from 
preflight to postflight with that from normovolemia to hypovolemia. 
Figure 5.  Epinephrine responses to tilt during normovolemia and hypovolemia in 
non-presyncopal and presyncopal subjects (right).  Previously published preflight and 
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postflight epinephrine responses to tilt have been re-plotted and are presented for 
comparison on the left (11). 
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